Peptides logo Elsevier logo

Publisher: Elsevier

Related content
Volume 22, Number 12, December 2001

< previous issue | all issues | next issue >

Peptide analog of fibronectin that inhibits cell migration and ERK 1/2 activity
pp. 1949-1953(5)
Authors: Szaniawska B.; Trembacz H.; Miloszewska J.; Lipkowski A.W.; Misicka A.; Ostrowski J.; Janik P.

Synergistic inhibitory activity of alpha- and beta-LFA-1 peptides on LFA-1/ICAM-1 interaction
pp. 1955-1962(8)
Authors: Yusuf-Makagiansar H.; Makagiansar I.T.; Hu Y.; Siahaan T.J.

Comparative study on the effect of phosphorylated TCR zeta chain ITAM sequences on early activation events in Jurkat T cells
pp. 1963-1971(9)
Authors: Chitu V.; Fajka-Boja R.; Toth G.K.; Varadi G.; Hegedus Z.; Franko A.; Szucs K.S.; Monostori E.

Prediction of signal peptides using scaled window
pp. 1973-1979(7)
Author: Chou K.-C.

Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding
pp. 1993-1998(6)
Authors: Buku A.; Price J.A.; Mendlowitz M.; Masur S.

Endogenous fragment of hemoglobin, neokyotorphin, as cell growth factor 1
pp. 1999-2008(10)
Authors: Blishchenko E.Y.; Kalinina O.A.; Sazonova O.V.; Khaidukov S.V.; Egorova N.S.; Surovoy A.Y.; Philippova M.M.; Vass A.A.; Karelin A.A.; Ivanov V.T.

Synthetic beta-endorphin-like peptide immunorphin binds to non-opioid receptors for beta-endorphin on T lymphocytes
pp. 2009-2013(5)
Authors: Navolotskaya E.V.; Malkova N.V.; Zargarova T.A.; Lepikhova T.N.; Zav'yalov V.P.; Lipkin V.M.

MDR1 P-glycoprotein transports endogenous opioid peptides
pp. 2015-2020(6)
Authors: Oude Elferink R.P.J.; Zadina J.

Analyzing the radiation of the proenkephalin gene in tetrapods: cloning of a Bombina orientalis proenkephalin cDNA
pp. 2021-2025(5)
Authors: Dores R.M.; Costantino D.; Walnutt J.; Danielson P.B.; Lecaude S.

Cloning, expression and processing of the CP2 neuropeptide precursor of Aplysia
pp. 2027-2038(12)
Authors: Vilim F.S.; Alexeeva V.; Moroz L.L.; Li L.; Moroz T.P.; Sweedler J.V.; Weiss K.R.

Differences between ranamargarin and other tachykinins in the stimulation of ion transport in frog skin
pp. 2039-2044(6)
Authors: Lippe C.; Bellantuono V.; Cassano G.; Quaranta A.; Ardizzone C.

Coding region of the sorbin gene in different species
pp. 2045-2053(9)
Authors: Wahbi K.; Magaud J.P.; Pansu D.; Descroix-Vagne M.

Identification of cDNA encoding motilin related peptide/ghrelin precursor from dog fundus
pp. 2055-2059(5)
Authors: Tomasetto C.; Wendling C.; Rio M.-C.; Poitras P.

C-type natriuretic peptide system in rabbit colon
pp. 2061-2068(8)
Authors: Hun Kim J.; Hee Jeon G.; Zoo Kim S.; Woo Cho K.; Hee Kim S.

Effects of endothelin-3 on intestinal ion transport
pp. 2069-2075(7)
Authors: Gonzalez Bosc L.V.; Majowicz M.P.; Ortiz M.C.; Vidal N.A.

The effect of alpha-melanocyte stimulating hormone on endotoxin-induced intestinal injury
pp. 2077-2082(6)
Authors: San T.; Oktar B.K.; Salik E.; Ercan F.; Alican I.

Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells
pp. 2083-2089(7)
Authors: Sheriff S.; Dautzenberg F.M.; Mulchahey J.J.; Pisarska M.; Hauger R.L.; Chance W.T.; Balasubramaniam A.; Kasckow J.W.

In vitro neuroprotection against glutamate-induced toxicity by pGlu-Glu-Pro-NH2 (EEP)1
pp. 2091-2097(7)
Authors: Koenig M.L.; Sgarlat C.M.; Yourick D.L.; Long J.B.; Meyerhoff J.L.

Isolation and characterization of serum procalcitonin from patients with sepsis
pp. 2099-2103(5)
Authors: Weglohner W.; Struck J.; Fischer-Schulz C.; Morgenthaler N.G.; Otto A.; Bohuon C.; Bergmann A.

Effects of peripheral and central administration of GHRH on feeding in aging LOU rats
pp. 2119-2126(8)
Authors: Veyrat-Durebex C.; Gaudreau P.; Boghossian S.; Alliot J.

Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase
pp. 2137-2144(8)
Authors: Silveira P.F.; Irazusta J.; Gil J.; Agirregoitia N.; Casis L.

Role of Asp297 of the AT2 receptor in high-affinity binding to different peptide ligands
pp. 2145-2149(5)
Authors: Knowle D.; Kurfis J.; Gavini N.; Pulakat L.

Pituitary adenylate cyclase-activating peptide inhibits neutrophil chemotaxis
pp. 2151-2154(4)
Authors: Kinhult J.; Uddman R.; Laan M.; Linden A.; Cardell L.-O.

Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line
pp. 2155-2162(8)
Authors: Lema-Kisoka R.; Hayez N.; Langer I.; Robberecht P.; Sariban E.; Delporte C.

Study on the hypothalamic factors mediating the inhibitory effect of PACAP38 on ovulation
pp. 2163-2168(6)
Authors: Kantor O.; Molnar J.; Heinzlmann A.; Arimura A.; Furst Z.; Koves K.

Radioiodination of the stable metabolic fragment of bradykinin, RPPGF
pp. 2169-2174(6)
Authors: Morinelli T.A.; Meier G.P.; Schey K.L.; Margolius H.S.

The effect of food deprivation and experimental diabetes on orexin and NPY mRNA levels
pp. 2175-2179(5)
Authors: Swart I.; Michael Overton J.; Houpt T.A.

Endogenous opiates: 2000
pp. 2257-2328(72)
Authors: Vaccarino A.L.; Kastin A.J.

Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
pp. 2329-2343(15)
Authors: Witt K.A.; Gillespie T.J.; Huber J.D.; Egleton R.D.; Davis T.P.

Author index
pp. 2345-2349(5)

Keyword index
pp. 2351-2356(6)

Volume contents
pp. 2357-2372(16)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page